MedTrace Logo

Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine Induced Paravertebral Block in Patients Undergonig Thoracotomy

NCT02397603 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-02-02

No results posted yet for this study

Summary

This study evaluates the effect of adding dexmedetomidine as an adjuvant to bupivacaine in patients undergoing thoracotomy when administered peri-neurally in thoracic paravertebral space.

Conditions

  • Acute Post-thoracotomy Pain

Interventions

DRUG

dexmedetomidine bupivacaine

perineural dexmedetomidine as an adjuvant to bupivacaine induced thoracic paravertebral block

DRUG

Bupivacaine saline

perineural bupivacaine saline mixture in the thoracic paravertebral catheter

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed Abdulatif, MD. · Professor of anesthesia, surgical intensive care and pain management cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02397603 on ClinicalTrials.gov